Bio Plus Co

Bio Plus Co Pre-Tax Margin

The Pre-Tax Profit Margin of Bio Plus Co (099430.KQ) as of Nov 19, 2026 is 19.29 %. In the previous year, Pre-Tax Profit Margin was 26.60 % — a change of -27.46% (lower).

Pre-Tax Margin

19.29 %

YoY

-27.46%

Last updated:

Pre-Tax Profit Margin of Bio Plus Co is 2025 19.29 % . Pre-Tax Profit Margin of Bio Plus Co was 2024 26.60 % . It decreases by -27.46% lower compared to the previous year.

The Bio Plus Co Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
26.15 KRW
Jan 1, 2019
39.48 KRW
Jan 1, 2020
49.80 KRW
Jan 1, 2021
37.86 KRW
Jan 1, 2022
48.43 KRW
Jan 1, 2023
50.34 KRW
Jan 1, 2024
26.60 KRW
Jan 1, 2025
19.29 KRW
The Bio Plus Co Pre-Tax Margin history
YEARPre-Tax MarginYoY
19.29 %-27.46%
26.60 %-47.16%
50.34 %+3.93%
48.43 %+27.92%
37.86 %-23.97%
49.80 %+26.14%
39.48 %+50.96%
26.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Plus Co Stock analysis

What does Bio Plus Co do? BioPlus Co., Ltd. generates revenue through the manufacturing and sale of dermal fillers, primarily hyaluronic acid fillers for temporary facial wrinkle improvement. The company also produces and sells anti-adhesion agents to prevent surgical adhesions, biomaterials for joint tissue repair, and other tissue restoration products. These products are supplied to medical professionals and healthcare facilities requiring cosmetic and surgical solutions. The firm targets the medical and cosmetic sectors, focusing on tissue restoration applications for both aesthetic and functional needs. The company's product portfolio includes biomaterials for tissue restoration, specifically designed for temporary facial wrinkle correction, anti-adhesion solutions for surgical sites, and joint tissue repair materials. These offerings cater to healthcare providers seeking advanced biomaterials for patient care. BioPlus Co., Ltd. serves the medical industry by providing specialized products that address both cosmetic enhancement and post-surgical recovery requirements. BioPlus Co., Ltd. operates within the biomaterials sector, focusing on dermal fillers and tissue repair solutions. Its products are utilized by medical practitioners for facial aesthetics and surgical applications. The company's revenue streams are derived from direct sales of these biomaterial products to healthcare institutions and professionals in the medical field. Bio Plus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Plus Co stock

Pre-Tax Profit Margin of Bio Plus Co is 19.29 % in 2025.

Pre-Tax Profit Margin of Bio Plus Co changed from 26.60 % to 19.29 %, representing a -27.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Bio Plus Co since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Bio Plus Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bio Plus Co

All Key Metrics — Bio Plus Co